Assembly Biosciences (ASMB) FCF Margin (2017 - 2026)

Assembly Biosciences' FCF Margin history runs 9 years deep, the most recent figure standing at 269.28% for Q1 2026.

• On a quarterly basis, FCF Margin fell 2043.0% year-over-year to 269.28% in Q1 2026; TTM through Mar 2026 was 56.03%, a 11877.0% increase from a year earlier, with the FY2025 full-year figure at 56.93%, up 12240.0% from the prior year.
• FCF Margin declined to 269.28% in Q1 2026 per ASMB's latest filing, from 33.47% in the prior quarter.
• Across five years, FCF Margin topped out at 1038.78% in Q4 2023 and bottomed at 317.68% in Q1 2024.
• The 4-year median for FCF Margin is 187.34% (2024), against an average of 50.71%.
• Across the five-year window, FCF Margin tumbled 104431 bps in 2024 and jumped 8205 bps in 2025, its largest moves.
• Year by year, FCF Margin stood at 1038.78% in 2023, then tumbled by 101 bps to 5.53% in 2024, then jumped by 705 bps to 33.47% in 2025, then plunged by 905 bps to 269.28% in 2026.
• Per Business Quant, the three latest ASMB FCF Margin figures stand at 269.28% (Q1 2026), 33.47% (Q4 2025), and 140.65% (Q3 2025).